{{Rsnum
|rsid=5743312
|Gene=TLR3
|Chromosome=4
|position=186079102
|Orientation=plus
|GMAF=0.1478
|Gene_s=TLR3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 71.7 | 27.4 | 0.9
| HCB | 58.4 | 38.0 | 3.6
| JPT | 51.3 | 40.7 | 8.0
| YRI | 84.4 | 15.0 | 0.7
| ASW | 77.2 | 22.8 | 0.0
| CHB | 58.4 | 38.0 | 3.6
| CHD | 63.3 | 33.0 | 3.7
| GIH | 76.2 | 19.8 | 4.0
| LWK | 82.7 | 17.3 | 0.0
| MEX | 84.5 | 12.1 | 3.4
| MKK | 69.2 | 26.3 | 4.5
| TSI | 67.6 | 32.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22205660
|Title=Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine
|OA=1
}}

{{PMID Auto
|PMID=22825813
|Title=Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients
}}

{{PMID Auto
|PMID=24028589
|Title=TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk
}}

{{PMID Auto
|PMID=22912896
|Title=HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}